<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">Gates Open Res</journal-id>
            <journal-title-group>
                <journal-title>Gates Open Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2572-4754</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/gatesopenres.13359.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Study Protocol</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Protocol for a scoping review of neonatal emollient therapy and massage practices throughout sub-Saharan Africa</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 2 approved, 1 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Blanks</surname>
                        <given-names>Keona J.H.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Musaba</surname>
                        <given-names>Milton W.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ren</surname>
                        <given-names>Lily</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Burgoine</surname>
                        <given-names>Kathy</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mukunya</surname>
                        <given-names>David</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Clarke</surname>
                        <given-names>Andrew</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-3127-5309</uri>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Williams</surname>
                        <given-names>Sarah</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Gebremichael</surname>
                        <given-names>Tewodros</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Waiswa</surname>
                        <given-names>Peter</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-9868-0515</uri>
                    <xref ref-type="aff" rid="a8">8</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Darmstadt</surname>
                        <given-names>Gary L.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-7522-5824</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a9">9</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Stanford University, 450 Serra Mall, Stanford, CA, 94305, USA</aff>
                <aff id="a2">
                    <label>2</label>Department of Obstetrics and Gynaecology, Busitema University Faculty of Health Sciences, Pallisa, Mbale, PO Box 1460, Uganda</aff>
                <aff id="a3">
                    <label>3</label>Lane Medical Library &amp; Knowledge Management Center, Stanford Medicine, Stanford University, 300 Pasteur Drive, L109, Stanford, CA, 94305, USA</aff>
                <aff id="a4">
                    <label>4</label>Mbale Clinical Research Institute, Plot 29, 33 Pallisa, Mbale, Uganda</aff>
                <aff id="a5">
                    <label>5</label>Busitema University Faculty of Health Sciences, Pallisa, Mbale, PO Box 1460, Uganda</aff>
                <aff id="a6">
                    <label>6</label>Sanyu Africa Research Institute, Mbale, PO Box 2190, Uganda</aff>
                <aff id="a7">
                    <label>7</label>Global Programs, Save the Children UK, 1 St John's Ln, London, EC1M 4AR, UK</aff>
                <aff id="a8">
                    <label>8</label>Makerere University, University Rd, Kampala, Uganda</aff>
                <aff id="a9">
                    <label>9</label>Department of Pediatrics, Stanford University School of Medicine, 1701 Page Mill Road, Palo Alto, Stanford, CA, 94304, USA</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:gdarmsta@stanford.edu">gdarmsta@stanford.edu</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>24</day>
                <month>8</month>
                <year>2021</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2021</year>
            </pub-date>
            <volume>5</volume>
            <elocation-id>142</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>17</day>
                    <month>8</month>
                    <year>2021</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Blanks KJH et al.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://gatesopenresearch.org/articles/5-142/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> Serious infections and other complications from very low birth weight and prematurity are the leading causes of death for neonates worldwide. Infections partly result from the compromised skin barrier function in preterm neonates. Optimal skin care practices for neonates, especially in settings with limited access to adequate hygienic conditions, hold potential to reduce infection and avoid these preventable preterm neonatal deaths. The purpose of this protocol is to support a scoping review of neonatal skin care, emollient therapy and massage practices throughout sub-Saharan Africa.</p>
                <p>
                    <bold>Protocol:</bold> The proposed review will follow a methodological framework consisting of the following five steps: (i) identifying the research question, (ii) identifying relevant studies, (iii) selection of eligible studies, (iv) charting the data, and (v) collating and summarizing the results. In addition, we will reflect on the implications of the findings for the feasibility and design of randomized controlled trials to examine the impact of emollient therapy on survival, growth, infection and neurodevelopment of very low birth weight infants in sub-Saharan Africa. We will search domestic and international databases for literature published in English between January 1, 2000, and July 12, 2021. Articles will be chosen based on standardized inclusion criteria. The primary criteria for inclusion will be a report on skin care practices administered to neonates in Africa.</p>
                <p>
                    <bold>Conclusions:</bold> Documentation of common neonatal skin care practices throughout Africa has the potential to highlight opportunities for skin care intervention and future research on neonatal skin care practices in sub-Saharan Africa, and support the development of future emollient intervention trials for preterm and low birthweight neonates in low- and middle-income countries.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Neonatology</kwd>
                <kwd>Emollient</kwd>
                <kwd>Massage</kwd>
                <kwd>Bathing</kwd>
                <kwd>Africa</kwd>
                <kwd>Low- and middle-income countries</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>King Center for Global Development, Stanford University</funding-source>
                </award-group>
                <award-group id="fund-2">
                    <funding-source>Gates Foundation</funding-source>
                    <award-id>INV-020497</award-id>
                </award-group>
                <funding-statement>This work was supported by the Gates Foundation [INV-020497] (GLD). The Gates Foundation grants OPP124589 and OPP438721 inspired the review but did not directly fund this work. KJHB was supported by the King Center for Global Development at Stanford University.</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p>The neonatal mortality rate in sub-Saharan Africa is the highest in the world, estimated at 27 deaths per 1,000 live births
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. Worldwide, 98% of all neonatal deaths occur in low- and middle-income countries (LMICs) and are largely ascribed to serious infections, complications from prematurity and birth asphyxia
                <sup>
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>. Compromised skin barrier function is an important factor in the complications associated with preterm birth
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. Lacking in vernix, a protective antimicrobial layer, the skin barrier of preterm infants is functionally compromised and has heightened susceptibility to injury, leading to increased risk for invasive infection and death
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>. Compounding the issue are maternal malnutrition, neonatal growth restriction and virulent pathogens that pervade unsterile environments in low-resource settings and potentially impact newborn infants at population-level
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>,
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>. Even in hospitals, overcrowding, limited staffing, unreliable water supply, lack of alcohol-based hand wash and lack of bleach and soap for basic cleaning of equipment further exacerbate poor sterilization and disinfection practices.</p>
            <p>Topical emollient therapy to the skin of preterm infants is a nascent intervention for neonatal care in LMICs. Emerging evidence suggests that emollient therapy promotes postnatal growth and reduces hospital-acquired infection and has potential to reduce mortality and enhance neurodevelopmental outcome
                <sup>
                    <xref ref-type="bibr" rid="ref-7">7</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup>. While application of oils and other products to the newborn infant is a widespread cultural practice in South Asia, less is known about this behavior in sub-Saharan Africa
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>. There have likewise been few reports of the effects of emollient therapy on newborn health in sub-Saharan Africa
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>,
                    <xref ref-type="bibr" rid="ref-12">12</xref>
                </sup>.</p>
            <p>The main objective for the proposed scoping review is to create an accurate depiction of newborn skin care practices in Africa, and to illuminate opportunities for intervention. This review will address the questions of &#x201c;what are the common newborn skin care practices throughout Africa, with a focus on bathing, the application of oils and other products, and massage?&#x201d; and &#x201c;what is the reported impact of newborn skin care practices throughout Africa, for example the impact of emollient therapy on newborn postnatal survival, growth, infection and neurodevelopment?&#x201d; This information would be critical for researchers planning effective intervention trials in Africa.</p>
        </sec>
        <sec>
            <title>Protocol</title>
            <p>This protocol is reported in line with the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) checklist
                <sup>
                    <xref ref-type="bibr" rid="ref-13">13</xref>
                </sup>.</p>
            <sec>
                <title>Scoping review</title>
                <p>This protocol is for a scoping review of literature reporting on common neonatal skin care practices throughout sub-Saharan Africa, with a focus on bathing, the application of oils and other products, and massage. A scoping review method was selected for its aims to delineate and identify gaps in available evidence on the area of focus. The proposed review will follow a methodological framework proposed by Arksey and O&#x2019;Malley
                    <sup>
                        <xref ref-type="bibr" rid="ref-14">14</xref>
                    </sup>. The framework consists of the following five steps: (i) identifying the research question, (ii) identifying relevant studies, (iii) selection of eligible studies, (iv) charting the data, and (v) collating and summarizing the results. Quality appraisal will not be done as this review aims to map all research activities in this field.</p>
            </sec>
            <sec>
                <title>Identifying the research question</title>
                <p>The main research questions are &#x201c;what are the common newborn skin care practices throughout sub-Saharan Africa, with a focus on bathing, the application of oils and other products, and massage?&#x201d; and &#x201c;what is the reported impact of newborn skin care practices throughout Africa, for example the impact of emollient therapy on survival, growth, infection and neurodevelopment?&#x201d;</p>
                <p>This study will use a series of guiding queries to align the study selection with the research question (see below, Charting the data). Since most of the studies relevant to this review are qualitative or observational in design (interviews, focus group discussions, and surveys), this approach was selected in lieu of the Population, Exposure, Comparator, and Outcomes (PECO) framework to allow for the inclusion of these studies. Randomized control trials (RCTs) and quasi experimental clinical trials will also be aligned in this manner.</p>
            </sec>
            <sec>
                <title>Identifying relevant studies</title>
                <p>A search will be conducted for published and unpublished (grey) literature on the research question in the following electronic databases: 
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://www.scopus.com/home.uri">Scopus</ext-link> (Elsevier), 
                    <ext-link ext-link-type="uri" xlink:href="https://www.embase.com/">Embase</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://www.webofscience.com/wos/woscc/basic-search">Web of Science</ext-link> (Clarivate Analytics), and 
                    <ext-link ext-link-type="uri" xlink:href="https://www.wolterskluwer.com/en/solutions/ovid/apa-psycinfo-139">PsycINFO</ext-link> (Ovid). Sources of grey literature will include: 
                    <ext-link ext-link-type="uri" xlink:href="http://www.opengrey.eu/">OpenGrey</ext-link> and 
                    <ext-link ext-link-type="uri" xlink:href="http://www.greynet.org/">GreyNet</ext-link>. Studies published prior to July 2021 that have the keywords or Medical Subject Headings (MeSH) terms delineated in the search strategy (
                    <xref ref-type="table" rid="T1">Table 1</xref>) will be identified. The search strategy will be piloted to check the appropriateness of keywords and databases. A hand (&#x201c;snowballing&#x201d;) search will also be conducted of the references of the included studies and websites such as the World Health Organization (WHO) to identify potentially relevant literature. Grey literature will also be identified through direct queries to authors of included literature to explore whether they are aware of unpublished literature on the topic</p>
                <table-wrap id="T1" orientation="portrait" position="anchor">
                    <label>Table 1. </label>
                    <caption>
                        <title>PubMed search strategy for a scoping review of neonatal emollient therapy and massage practices throughout sub-Saharan Africa.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1">SearchActionsDetailsQueryResults
                                    <break/>Search: 
                                    <bold>#4 NOT #5</bold> Filters: 
                                    <bold>from 2000 - 2021</bold>
                                    <break/>3,48516:16:43#21
                                    <break/>Search: 
                                    <bold>#4 NOT #5</bold>
                                    <break/>216:16:07#5
                                    <break/>Search: 
                                    <bold>"animals"[mesh] NOT ("animals"[mesh] AND "humans"[mesh])</bold>
                                    <break/>4,843,98816:15:38#4
                                    <break/>Search: 
                                    <bold>#1 AND #2 AND #3</bold>
                                    <break/>Search: 
                                    <bold>"Infant, Newborn"[Mesh] or "Infant Care"[Mesh] or infant* or neonat* or newborn* or "new born*" or "Child Rearing"[mesh] or "child rear*"[tw] or childrear*[tw] or childbear*[tw] or "Postpartum Period"[Mesh] or "postpartum"[tw]</bold>
                                    <break/>1,678,41916:01:31#2
                                    <break/>Search: 
                                    <bold>"africa"[Mesh] or "africa*"[tw] or "sudan*"[tw] or "western sahara*"[tw] or "algeria*"[tw] or "egypt*"[tw] or "libya*"[tw] or "morocc*"[tw] or "tunisia*"[tw] or "Cairo"[tw] or "Rabat"[tw] or "Casablanca"[tw] or "Tripoli"[tw] or "Algiers"[tw] or "Fes"[tw] or "Marrakesh"[tw] or "Tunis"[tw] or "Carthage"[tw] or "Tangier"[tw] or "Kairouan"[tw] or "Essaouira"[tw] or "Luxor"[tw] or "Bizerte"[tw] or "El Aaiun"[tw] or "Sousse"[tw] or "Oran"[tw] or "Annaba"[tw] or "Constantine"[tw] or "Biskra"[tw] or "Chefchaoouen"[tw] or "Skikda"[tw] or "Sharm El Sheikh"[tw] or "Volubilis"[tw] or "El Oued"[tw] or "Meknes"[tw] or "Hippo Regius"[tw] or "Djemila"[tw] or "Sfax"[tw] or "Tataouine"[tw] or "port Said"[tw] or "Ait Benhaddou"[tw] or "Benghazi"[tw] or "Juba"[tw] or "Tamanrasette"[tw] or "merzouga"[tw] or "El Djem"[tw] or "oujda"[tw] or "Matmata"[tw] or "Ghat"[tw] or "Tabessa"[tw] or "Giza"[tw] or "Marj"[tw] or "Ifrane"[tw] or "Agadir"[tw] or "Tetouan"[tw] or "Shubra El Kheima"[tw] or "Tobruk"[tw] or "Khartoum"[tw] or "Nyala"[tw] or "Kassala"[tw] or "Ubayyid"[tw] or "Kosti"[tw] or "Wad Madani"[tw] or "Qadarif"[tw] or "Al-Fashir"[tw] or "Daein"[tw] or "Damazin"[tw] or "Geneina"[tw] or "Merowe"[tw] rr "Sahara"[tw] or "British Indian Ocean Territory"[tw] or "Burundi*"[tw] or "Comoros"[tw] or "Djibouti*"[tw] or "Eritrea*"[tw] or "Ethiopia*"[tw] or "Kenya*"[tw] or "Madagascar"[tw] or "Malawi"[tw] or "Mauritius"[tw] or "Mayotte"[tw] or "Mozambique"[tw] or "Reunion"[tw] OR "Rwanda*"[tw] or "Seychelles"[tw] or "Somalia*"[tw] or "Sudan*"[tw] or "Tanzania*"[tw] or "Uganda*"[tw] or "Zambia"[tw] or "Zimbabwe"[tw] or "Crozet Islands"[tw] or "Iles Crozet"[tw] or "Scattered Islands"[tw] or "Iles Eparses"[tw] or "Addis Ababa"[tw] or "Asmara"[tw] or "Anananarivo"[tw] or "Arusha"[tw] or "Axum"[tw] or "Bahir Dar"[tw] or "Berbera"[tw] or "Bulawayo"[tw] or "Dese"[tw] or "Eldoret"[tw] or "Garissa"[tw] or "Geita"[tw] or "Gondar"[tw] or "Great Rift Valley"[tw] or "Hargeisa"[tw] or "Hargeysa"[tw] or "Hola"[tw] or "Jinja"[tw] or "Iringa"[tw] or "Kigoma"[tw] or "Jimma"[tw] or "Korogwe"[tw] or "Nairobi"[tw] or "Dar es Salaam"[tw] or "Mombasa"[tw] or "Mogadishu"[tw] or "Dodomoa"[tw] or "Bujumbura"[tw] or "Mbeya"[tw] or "Lusaka"[tw] or "Harare"[tw] or "Kakamega"[tw] or "Kampala"[tw] or "Kigali"[tw] or "Kire Dawa"[tw] or "Kikuyu"[tw] or "Kisumu"[tw] or "Kitale"[tw] or "Kitui"[tw] or "Lilongwe"[tw] or "Lake Victoria"[tw] or "Lake Tanganyika"[tw] or "Lamu"[tw] or "Lodwar"[tw] or "Lokichogio"[tw] or "Malindi"[tw] or "Machakos"[tw] or "Marka"[tw] or "Machakos"[tw] or "Maputo"[tw] or "Maralal"[tw] or "Mekele"[tw] or "Meru"[tw] or "Musoma"[tw] or "Mtwara"[tw] or "Mumias"[tw] or "Moshi"[tw] or "Moroni"[tw] or "Morogoro"[tw] or "Mwanza"[tw] or "Naivasha"[tw] or "Nanyuki"[tw] or "Nakuru "[tw] or "Namanga"[tw] or "Nyeri"[tw] or "Port Louis"[tw] or "Puntland*"[tw] or "Nyahururu"[tw] or "Kismayo"[tw] or "Ruiru"[tw] or "Rwenzori Mountains"[tw] or "Sinyanga"[tw] or "Songea"[tw] or "tanga"[tw] or "Tabora"[tw] or "voi"[tw] or "webuye"[tw] or "Zanzibar"[tw] or "Adiharush"[tw] or "Ali-Addeh"[tw] or "Alinjugur"[tw] or "Buramino"[tw] or "Dadaab"[tw] or "Dagahaley"[tw] or "Dollo Ado"[tw] or "Fugnido"[tw] or "Hagadera"[tw] or "Hilaweyn"[tw] or "Ifo"[tw] or "Kakuma"[tw] or "Kambioos"[tw] or "Kayaka II"[tw] or "Kobe"[tw] or "Kyangwali Nakivale"[tw] or "Nyarugusu"[tw] or "Wad Sherife"[tw] or "Bokolmanyo"[tw] or "Melkadida"[tw] or "Rwamanja"[tw] or "benin*"[tw] or "burkina fas"[tw] or "cape verd*"[tw] or "cabo verd*"[tw] or "ivory coast"[tw] or "cote divoire*"[tw] or "gambia*"[tw] or "ghana*"[tw] or "guinea*"[tw] or "bissau"[tw] or "liberia map"[tw] or "malian"[tw] or "mauritania*"[tw] or "nigeria*"[tw] or "senegal*"[tw] or "sierra leon*"[tw] or "togo*"[tw] or "Lagos"[tw] or "Accra"[tw] or "Abidjan"[tw] or "Dakar"[tw] or "Abobo"[tw] or "Abuja"[tw] or "Freetown"[tw] or "Ouagadougou"[tw] or "Conakry"[tw] or "Lome"[tw] or "Bamako"[tw] or "Cotonou"[tw] or "Kumasi"[tw] or "Monrovia"[tw] or "Ibadan"[tw] or "Kano"[tw] or "Port harcourt"[tw] or "Benin City"[tw] or "Porto Novo"[tw] or "Niamey"[tw] or "Yamoussoukro"[tw] or "Banjul"[tw] or "Timbuktu"[tw] or "Djenne"[tw] or "Abomeyu"[tw] or "Zaria"[tw] or "Tamale"[tw] or "Jos"[tw] or "Cape Coast"[tw] or "Maidugul"[tw] or "Aba"[tw] or "Gao"[tw] or "Calabar"[tw] or "Warri"[tw] or "Maiduguri"[tw] or "Bobo Dioulasso"[tw] or "Parakou"[tw] or "Djougou"[tw] or "Bohicon"[tw] or "Sekondi Takoradi"[tw] or "Sunyani"[tw] or "Obuasi"[tw] or "Teshie"[tw] or "Tema"[tw] or "Sikasso"[tw] or "Kalabankoro"[tw] or "Nouakchott"[tw] or "Dakhlet Nouadhibou"[tw] or "Benin City"[tw] or "Port Harcourt"[tw] or "Ilorin"[tw] or "Kaduna"[tw] or "Enugu"[tw] or "Ikorodu"[tw] or "Onitsha"[tw] or "Bauchi"[tw] or "Akure"[tw] or "Abeokuta"[tw] or "Sokoto"[tw] or "Bouake"[tw] or "Makeni"[tw] or "Kaduan"[tw] or "Sosgbo"[tw] or "Osogbo"[tw] or "Gombe"[tw] or "Ilesa"[tw] or "Badagry"[tw] or "makurdi"[tw] or "Sagamu"[tw] or "Iseyin"[tw] or "obbomosho"[tw] or "Awka"[tw] or "Ado Ekiti"[tw] or "Nsukka"[tw] or "Ikeja"[tw] or "Katsina"[tw] or "Okene"[tw] or "Lafia"[tw] or "Minna"[tw] or "Ondo city"[tw] or "Umuahia"[tw] or "Calabar"[tw] or "Yola"[tw] or "Pikine"[tw] or "Touba"[tw] or "Thies Nones"[tw] or "Saint Louis"[tw] or "Kolak"[tw] or "Ziguinch"[tw] or "San Pedro"[tw] or "Bandama"[tw] or "Daloa"[tw] or "Owerri"[tw] or "Kandi"[tw] or "Ifi"[tw] or "Dakar"[tw] or "Ogbomosho"[tw] or "Divo"[tw] or "Korhogo"[tw] or "angola"[tw] or "cameroon*"[tw] or "chad"[tw] or "tchad"[tw] or "congo*"[tw] or "DRC"[tw] or "equatorial guinea*"[tw] or "gabon*"[tw] or "Sao Tome"[tw] or "Principe"[tw] or "Luanda"[tw] or "lobito"[tw] or "kuito"[tw] or "huambo"[tw] or "Malanje"[tw] or "Douala"[tw] or "Yaounde"[tw] or "Bamenda"[tw] or "Garoua of Bafoussam"[tw] or "Nganoundere"[tw] or "Maroua"[tw] or "Kouosseri"[tw] or "Buena"[tw] or "Kumba"[tw] or "N Djamena"[tw] or "Moundou"[tw] or "Bangui"[tw] or "Bimbo"[tw] or "Brazzaville"[tw] or "Point Noire"[tw] or "Kinshasa"[tw] or "Lubumbashi"[tw] or "Leopoldville"[tw] or "Elizabethville"[tw] or "Mbuji Mayi"[tw] or "Bakwanga"[tw] or "Bukavu"[tw] or "Costermansville"[tw] or "Kananga"[tw] or "Luluabourg"[tw] or "Kisangani"[tw] or "Stanleyville"[tw] or "Tshikapa"[tw] or "Koalwezi"[tw] or "Likasi"[tw] or "Jadotville"[tw] or "Goma"[tw] or "Kikwit"[tw] or "Uvira"[tw] or "Bunia"[tw] or "Mbandaka"[tw] or "Coquilhatville"[tw] or "Matadi"[tw] or "Butembo"[tw] or "Kabinda"[tw] or "Mwene Ditu"[tw] or "Isiro"[tw] or "Paulis"[tw] or "Boma"[tw] or "Kindu"[tw] or "Bata"[tw] or "Malabo"[tw] or "Libreville"[tw] or "botswana*"[tw] or "lesotho*"[tw] or "malawi*"[tw] or "mozambiq*"[tw] or "namibia*"[tw] or "swaziland"[tw] or "zambia*"[tw] or "zimbabwe"[tw] or "Zulu"[tw] or "Tsonga"[tw] or "Xhosa"[tw] or "Swazi"[tw] or "Ndebele"[tw] or "Tswana"[tw] or "Sotho"[tw] or "Shona people"[tw] or "BaLunda"[tw] or "Mbundu"[tw] or "Ovimbundu"[tw] or "Chaga"[tw] or "Sukuma"[tw] or "Pretoria"[tw] or "Cape Town"[tw] or "Johannesburg"[tw] or "Durban"[tw] or "Port Elizabeth"[tw] or "Bloemfontein"[tw] or "Windhoek"[tw] or "Maseru"[tw] or "Pietermaritz"[tw] or "Kimberley"[tw] or "Nespruit"[tw] or "Soweto"[tw] or "Polokwane"[tw] or "Limpopo"[tw] or "Rustenburg"[tw] or "Mahikeng"[tw] or "Oudtshroom"[tw] or "Stellenbosch"[tw] or "Paarl"[tw] or "Gaborone"[tw] or "Luanda"[tw] or "Cabinda"[tw] or "Huambo"[tw] or "Lubango"[tw] or "Kuit"[tw] or "Malanje"[tw] or "Lobito"[tw] or "Lilongwe"[tw] or "Blantyre"[tw] or "Mzuzu"[tw] or "Maputo"[tw] or "Matola"[tw] or "Beira"[tw] or "Nampula"[tw] or "Chimoio"[tw] or "Nacala"[tw] or "Quelimane"[tw] or "Lusaka"[tw] or "Kitwe"[tw] or "Ndola"[tw] or "Kabwe"[tw] or "Copperbelt Harare"[tw] or "Bulawayo"[tw] or "Chitungwiza"[tw] or "Mutare"[tw] or "Masvingo"[tw] or "Monashonaland"[tw] or "Manicaland"[tw]</bold>
                                    <break/>440,31416:00:48#1
                                    <break/>Search: 
                                    <bold>"Skin"[Mesh] or "Skin Care"[Mesh] or "Emollients"[Mesh] or "emollient*"[tw] or (("skin"[tw] or oil[tw] or derm*[tw] or epiderm*[tw] or massage*[tw]) AND (practice*[tw] or care[tw] or treatment*[tw] or therap*[tw] or product*[tw])) or "Massage"[Mesh] or "massage*"[tw] or "Baths"[Mesh] or "bath"[tw] or "baths"[tw] or "bathing"[tw] or "Oils"[Mesh] or "oil"[tw] or "oils"[tw] or "Aloe"[Mesh] or "aloe"[tw] or "Perinatal care"[mesh] or "postnatal care"[mesh] or "perinatal care"[tw] or "antenatal care"[tw] or "Home Care Services"[mesh] or "home care"[tw] or "Hygiene"[mesh] or hygiene[tw]</bold>
                                    <break/>1,087,81916:00:09</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec>
                <title>Selection of eligible studies</title>
                <p>Title and abstract screening will be guided by a series of queries (
                    <xref ref-type="table" rid="T2">Table 2</xref>). Further eligibility criteria will ensure that the content of the included studies is relevant to the research question.</p>
                <table-wrap id="T2" orientation="portrait" position="anchor">
                    <label>Table 2. </label>
                    <caption>
                        <title>Guiding queries used to electronically capture relevant information from each included study.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1">1.&#x00a0;&#x00a0;
                                    <underline>Author and Date</underline>
                                    <break/>2.&#x00a0;&#x00a0;
                                    <underline>Title of Study</underline>
                                    <break/>3.&#x00a0;&#x00a0;
                                    <underline>What was the sample size?</underline>
                                    <break/>4.&#x00a0;&#x00a0;
                                    <underline>Where was the study done (city/district/province/country)?</underline>
                                    <break/>5.&#x00a0;&#x00a0;
                                    <underline>Was the study done in a hospital (what level?) or home setting?</underline>
                                    <break/>6.&#x00a0;&#x00a0;
                                    <underline>What was the gestational age of the neonates?</underline>
                                    <break/>7.&#x00a0;&#x00a0;
                                    <underline>What was the chronological age of the neonates? </underline>
                                    <break/>8.&#x00a0;&#x00a0;
                                    <underline>What substance was applied?</underline>
                                    <break/>9.&#x00a0;&#x00a0;
                                    <underline>Was the substance applied to the umbilical cord? </underline>
                                    <break/>10.&#x00a0;&#x00a0;
                                    <underline>How often was the substance applied?</underline>
                                    <break/>11.&#x00a0;&#x00a0;
                                    <underline>By whom was the substance applied? </underline>
                                    <break/>12.&#x00a0;&#x00a0;
                                    <underline>How was the substance applied?</underline>
                                    <break/>13.&#x00a0;&#x00a0;
                                    <underline>How was the substance distributed on the body (i.e applied to the nappy area, the scalp, etc)?</underline>
                                    <break/>14.&#x00a0;&#x00a0;
                                    <underline>What are the health impacts of product application?</underline>
                                    <break/>15.&#x00a0;&#x00a0;
                                    <underline>What is the acceptability of the product to those involved in the study?</underline>
                                    <break/>16.&#x00a0;&#x00a0;
                                    <underline>What product preferences do those involved in the study hold, if any?</underline>
                                    <break/>17.&#x00a0;&#x00a0;
                                    <underline>Was the neonate massaged, and if so, how was the massage performed?</underline>
                                    <break/>18.&#x00a0;&#x00a0;
                                    <underline>Why was this substance applied? (belief)</underline>
                                    <break/>19.&#x00a0;&#x00a0;
                                    <underline>With what was the neonate bathed?</underline>
                                    <break/>20.&#x00a0;&#x00a0;
                                    <underline>What was the temperature of the bath water?</underline>
                                    <break/>21.&#x00a0;&#x00a0;
                                    <underline>Was anything applied to skin after bathing? (If yes, what was applied?)</underline>
                                    <break/>22.&#x00a0;&#x00a0;
                                    <underline>By whom were the neonates bathed?</underline>
                                    <break/>23.&#x00a0;&#x00a0;
                                    <underline>How often were the neonates bathed?</underline>
                                    <break/>24.&#x00a0;&#x00a0;
                                    <underline>Why was the neonate bathed in this way (belief)?</underline>
                                    <break/>25.&#x00a0;&#x00a0;
                                    <underline>What was the mode of delivery, if recorded (i.e., spontaneous vaginal delivery, cesarean section, etc)?</underline>
                                    <break/>26.&#x00a0;&#x00a0;
                                    <underline>What were the outcome measures, if any?</underline>
                                    <break/>27.&#x00a0;&#x00a0;
                                    <underline>What observations were made about neonates' response?</underline>
                                    <break/>28.&#x00a0;&#x00a0;
                                    <underline>What descriptive norm(s), If any, influenced this scenario?</underline>
                                    <break/>29.&#x00a0;&#x00a0;
                                    <underline>What injunctive norm(s), If any, influenced this scenario?</underline>
                                    <break/>30.&#x00a0;&#x00a0;
                                    <underline>What perceived sanctions of norm(s), If any, influenced this scenario?</underline>
                                </td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>
                    <underline>Inclusion criteria</underline>
                </p>
                <p>For studies to be included, they must meet the following criteria:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>Report on skin care practices administered to newborns</p>
                    </list-item>
                    <list-item>
                        <p>Include participants from sub-Saharan Africa</p>
                    </list-item>
                    <list-item>
                        <p>Published after 1 January 2000 and prior to 1 July 2021</p>
                    </list-item>
                    <list-item>
                        <p>Qualitative and quantitative studies</p>
                    </list-item>
                </list>
                <p>
                    <underline>Exclusion criteria</underline>
                </p>
                <p>Studies will be excluded if they have any of the following characteristics:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>Studies that do not include participants from Africa</p>
                    </list-item>
                    <list-item>
                        <p>Multi-center or multi-country studies reporting data from Africa that cannot be isolated from mixed summary data that includes non-African countries</p>
                    </list-item>
                    <list-item>
                        <p>Studies with an exclusive focus on umbilical cord care and/or bathing practices, and an absence of information on emollient applications to the skin</p>
                    </list-item>
                    <list-item>
                        <p>Studies that are not available in English or French</p>
                    </list-item>
                    <list-item>
                        <p>Studies where full-text of the article could not be obtained</p>
                    </list-item>
                </list>
                <p>The electronic database search will be recorded in a table (see 
                    <xref ref-type="table" rid="T3">Table 3</xref>). All eligible articles will be uploaded into the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.covidence.org/">Covidence</ext-link> software, and duplicates identified and removed. Title and abstract screening of all eligible articles will be conducted to determine whether the study should be included in the review or not. All attempts will be made to obtain full texts of selected articles, by searching the web, engaging with librarians from University of Oxford, University of Makerere in Uganda, Busitema University Faculty of Health Science in Uganda, and Stanford University, or contacting an author if necessary. Two investigators will conduct full-text screening of the selected studies. A third reviewer will be employed if there are significant discrepancies that cannot be resolved by discussion and consensus. The degree of agreement between reviewers will be calculated and reported.</p>
                <table-wrap id="T3" orientation="portrait" position="anchor">
                    <label>Table 3. </label>
                    <caption>
                        <title>Electronic database searches. </title>
                        <p>An illustrative draft of the table in which electronic database searches will be recorded.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Date of search</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Electronic database</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Keywords searched</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Number of studies retrieved</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Number of studies selected</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td colspan="1" rowspan="1"/>
                                <td align="left" colspan="1" rowspan="1" valign="top">PubMed</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">&#x201c;neonatal massage&#x201d; or &#x201c;newborn massage&#x201d;, AND &#x201c;Africa&#x201d;</td>
                                <td colspan="1" rowspan="1"/>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>The selection process will follow the recommendations in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) checklist
                    <sup>
                        <xref ref-type="bibr" rid="ref-15">15</xref>
                    </sup> and will be mapped using the PRISMA-P chart
                    <sup>
                        <xref ref-type="bibr" rid="ref-16">16</xref>
                    </sup>.</p>
            </sec>
            <sec>
                <title>Amendments</title>
                <p>Important protocol amendments will be documented in future protocol files and in the narrative report of the scoping review.</p>
            </sec>
            <sec>
                <title>Charting the data</title>
                <p>A data charting form will be used to electronically capture relevant information from each included study. The extracted data will include fields outlined in 
                    <xref ref-type="table" rid="T2">Table 2</xref>.</p>
            </sec>
            <sec>
                <title>Collating, summarizing and reporting the results</title>
                <p>A narrative report will be produced to summarize the extracted data for the following outcomes: region (country, province) of study, prevalence of skin care-related health conditions, associated factors for skin care-related health conditions and skin care practices for newborns. The final outcome will include two sub-foci: emollient and massage. For the former, data around the following outcomes will be extracted and summarized: sample size; location of study (city/district/province/country and hospital/home setting); gestational age of neonates; chronological age of neonates; type of substance applied to the skin; whether substance was applied to the umbilical cord; how often substance was applied; by whom the substance was applied; how the substance was applied; how the substance was distributed on the body (i.e. the scalp, nappy area etc.); health impacts of product application; acceptability of the product to those involved in the study; product preferences of those involved in the study; whether the neonate was massaged, and if so, how the massage was performed; why the substance was applied; with what the neonate was bathed; temperature of the bath water; whether anything was applied to the skin after bathing, and if so, what substance; by whom the neonates were bathed; how often the neonates were bathed; why the neonate was bathed in a particular way; the mode of delivery if recorded (i.e. SVD/CS); outcome measures, if any; observations about neonate response to care; descriptive, injunctive, and/or perceived sanctions of norm(s), if any, that influenced the scenario. Regarding massage, the following data will be extracted and summarized: type of massage performed, how massage is performed, how often massage is performed, when massage is performed, who performs the massage, rationale behind the selected massage technique, perceived benefits of the technique, any harms or concerns about the technique, and health impacts of the massage technique. These results will be described in relation to the research question and in the context of the overall study purpose. Gap analysis will identify areas where data on neonatal emollient therapy are still needed in sub-Saharan Africa.</p>
            </sec>
            <sec>
                <title>Dissemination</title>
                <p>The narrative report summarizing the data from the review will be disseminated in the public domain via publication in a relevant journal; circulation through the academic networks of review authors; and direct sharing to a team of researchers representing the University of Makerere in Uganda, Busitema University Faculty of Health Science in Uganda, Mbale Clinical Research Institute, Save the Children and Stanford University who are preparing for a clinical trial on neonatal emollient therapy in Uganda.</p>
            </sec>
            <sec>
                <title>Study status</title>
                <p>As of 5 August 2021, we have developed and validated the ability of the search strategy to capture a set of articles of known relevance
                    <sup>
                        <xref ref-type="bibr" rid="ref-10">10</xref>
                    </sup>, employed the search strategy to identify eligible articles, uploaded the titles and abstracts into 
                    <ext-link ext-link-type="uri" xlink:href="https://www.covidence.org/">Covidence</ext-link> software, and completed an initial screening of titles and abstracts to identify articles for full-text review.</p>
            </sec>
        </sec>
        <sec sec-type="discussion">
            <title>Discussion</title>
            <p>The proposed scoping review aims to identify and describe common newborn skin care practices throughout Africa, with a focus on bathing, the application of oils and massage. It will also highlight gaps in current knowledge on newborn skin care practices in Africa. As the quality of the studies will not be assessed, commentary cannot be provided regarding the reliability of data extracted from selected studies.</p>
            <p>We will reflect on the implications of the findings for the feasibility and design of randomized controlled trials to examine the impacts of emollient therapy on survival, postnatal growth and neurodevelopment of very low birth weight infants in Africa. This review will support the planning of effective emollient intervention trials for newborn health in the future, particularly in sub-Saharan Africa. The evidence gaps identified by this review will also capacitate governments, funders, and researchers to refine their focus on neglected research areas and accelerate impact in newborn skin care interventions in sub-Saharan Africa. This review also has the potential to equip policy makers and stakeholders with evidence to support the care of this high-risk group of very low birth weight infants in sub-Saharan Africa.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>No data are associated with this article.</p>
            <sec>
                <title>Reporting guidelines</title>
                <p>Stanford Digital Repository: PRISMA-P checklist for  &#x2018;Protocol for a scoping review of neonatal emollient therapy and massage practices throughout sub-Saharan Africa&#x2019;.</p>
                <p>
                    <ext-link ext-link-type="uri" xlink:href="https://purl.stanford.edu/zx021fw5637">https://purl.stanford.edu/zx021fw5637</ext-link>
                    <sup>
                        <xref ref-type="bibr" rid="ref-13">13</xref>
                    </sup>.</p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons Zero "No rights reserved" data waiver</ext-link> (CC0 1.0 Public domain dedication).</p>
            </sec>
        </sec>
    </body>
    <back>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <collab>United Nations Inter-agency Group for Child Mortality Estimation (UN IGME)</collab>:
                    <article-title> Levels &amp; Trends in Child Mortality: Report 2020, Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation.</article-title>United Nations Children&#x2019;s Fund, New York,<year> 2020</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.unicef.org/media/79371/file/UN-IGME-child-mortality-report-2020.pdf.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <collab>IISD</collab>:
                    <article-title>UN Report on Newborn and Child Mortality Rates on the Rise</article-title>. International institute for sustainable development.<year> 2017</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://sdg.iisd.org/news/un-report-finds-newborn-child-mortality-rates-on-the-rise/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yoshio</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tollin</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gudmundsson</surname>
                            <given-names>GH</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: Implications for newborn innate defense.</article-title>
                    <source>

                        <italic toggle="yes">Pediatr Res.</italic>
</source>
                    <year>2003</year>;<volume>53</volume>(<issue>2</issue>):<fpage>211</fpage>&#x2013;<lpage>216</lpage>.
                    <pub-id pub-id-type="pmid">12538777</pub-id>
                    <pub-id pub-id-type="doi">10.1203/01.PDR.0000047471.47777.B0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hammarlund</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sedin</surname>
                            <given-names>G</given-names>
                        </name>
</person-group>:
                    <article-title>Transepidermal water loss in newborn infants. III. relation to gestational age.</article-title>
                    <source>

                        <italic toggle="yes">Acta Paediatr Scand.</italic>
</source>
                    <year>1979</year>;<volume>68</volume>(<issue>6</issue>):<fpage>795</fpage>&#x2013;<lpage>801</lpage>.
                    <pub-id pub-id-type="pmid">539401</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1651-2227.1979.tb08214.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Darmstadt</surname>
                            <given-names>G</given-names>
                        </name>
</person-group>:
                    <article-title>The skin and nutritional disorders of the newborn.</article-title>
                    <source>

                        <italic toggle="yes">Eur J Pediatr Dermatol.</italic>
</source>
                    <year>1998</year>;<volume>8</volume>(<issue>4</issue>):<fpage>221</fpage>&#x2013;<lpage>228</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.ejpd.com/journal/index.php/EJPD/article/view/35">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bhutta</surname>
                            <given-names>ZA</given-names>
                        </name>
</person-group>:
                    <article-title>Neonatal bacterial infections in developing countries: strategies for prevention.</article-title>
                    <source>

                        <italic toggle="yes">Semin Neonatol.</italic>
</source>
                    <year>1999</year>;<volume>4</volume>(<issue>3</issue>):<fpage>159</fpage>&#x2013;<lpage>171</lpage>.
                    <pub-id pub-id-type="doi">10.1016/S1084-2756(99)90040-4</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Salam</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Das</surname>
                            <given-names>JK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Darmstadt</surname>
                            <given-names>GL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Emollient therapy for preterm newborn infants -- evidence from the developing world.</article-title>
                    <source>

                        <italic toggle="yes">BMC Public Health.</italic>
</source>
                    <year>2013</year>;<volume>13</volume>(<issue>Suppl 3</issue>):<fpage>S31</fpage>.
                    <pub-id pub-id-type="pmid">24564550</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1471-2458-13-S3-S31</pub-id>
                    <pub-id pub-id-type="pmcid">3878124</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Darmstadt</surname>
                            <given-names>GL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Saha</surname>
                            <given-names>SK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ahmed</surname>
                            <given-names>AS</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial.</article-title>
                    <source>

                        <italic toggle="yes">Lancet.</italic>
</source>
                    <year>2005</year>;<volume>365</volume>(<issue>9464</issue>):<fpage>1039</fpage>&#x2013;<lpage>45</lpage>.
                    <pub-id pub-id-type="pmid">15781099</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(05)71140-5</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cleminson </surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McGuire </surname>
                            <given-names>W</given-names>
                        </name>
</person-group>:
                    <article-title>Topical emollient for preventing infection in preterm infants.</article-title>
                    <source>

                        <italic toggle="yes">Cochrane Database Syst Rev.</italic>
</source>
                    <year>2021</year>;<volume>5</volume>(<issue>5</issue>):<fpage>CD001150</fpage>.
                    <pub-id pub-id-type="pmid">33961715</pub-id>
                    <pub-id pub-id-type="doi">10.1002/14651858.CD001150.pub4</pub-id>
                    <pub-id pub-id-type="pmcid">8104155</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Duffy</surname>
                            <given-names>JL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ferguson</surname>
                            <given-names>RM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Darmstadt</surname>
                            <given-names>GL</given-names>
                        </name>
</person-group>:
                    <article-title>Opportunities for improving, adapting and introducing emollient therapy and improved newborn skin care practices in Africa.</article-title>
                    <source>

                        <italic toggle="yes">J Trop Pediatr.</italic>
</source>
                    <year>2012</year>;<volume>58</volume>(<issue>2</issue>):<fpage>88</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">21558307</pub-id>
                    <pub-id pub-id-type="doi">10.1093/tropej/fmr039</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Darmstadt</surname>
                            <given-names>GL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Badrawi</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Law</surname>
                            <given-names>PA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Topically applied sunflower seed oil prevents invasive bacterial infections in preterm infants in Egypt: a randomized, controlled clinical trial.</article-title>
                    <source>

                        <italic toggle="yes">Pediatr Infect Dis J.</italic>
</source>
                    <year>2004</year>;<volume>23</volume>(<issue>8</issue>):<fpage>719</fpage>&#x2013;<lpage>25</lpage>.
                    <pub-id pub-id-type="pmid">15295221</pub-id>
                    <pub-id pub-id-type="doi">10.1097/01.inf.0000133047.50836.6f</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jabraeile</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rasooly</surname>
                            <given-names>AS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Farshi</surname>
                            <given-names>MR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Effect of olive oil massage on weight gain in preterm infants: A randomized controlled clinical trial.</article-title>
                    <source>

                        <italic toggle="yes">Niger Med J.</italic>
</source>
                    <year>2016</year>;<volume>57</volume>(<issue>3</issue>):<fpage>160</fpage>&#x2013;<lpage>3</lpage>.
                    <pub-id pub-id-type="pmid">27397955</pub-id>
                    <pub-id pub-id-type="doi">10.4103/0300-1652.184060</pub-id>
                    <pub-id pub-id-type="pmcid">4924397</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Blanks</surname>
                            <given-names>KJH</given-names>
                        </name>
</person-group>:
                    <article-title>PRISMA-P checklist for a manuscript titled "Protocol for a scoping review of neonatal emollient therapy and massage practices throughout sub-Saharan Africa"</article-title>.
                    <ext-link ext-link-type="uri" xlink:href="https://purl.stanford.edu/zx021fw5637">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Arksey</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>O'Malley</surname>
                            <given-names>L</given-names>
                        </name>
</person-group>:
                    <article-title>Scoping studies: towards a methodological framework.</article-title>
                    <source>

                        <italic toggle="yes">Int J Soc Res Methodol.</italic>
</source>
                    <year>2005</year>;<volume>8</volume>(<issue>1</issue>):<fpage>19</fpage>&#x2013;<lpage>32</lpage>.
                    <pub-id pub-id-type="doi">10.1080/1364557032000119616</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tricco</surname>
                            <given-names>AC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lillie</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zarin</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.</article-title>
                    <source>

                        <italic toggle="yes">Ann Int Med.</italic>
</source>
                    <year>2018</year>;<volume>169</volume>(<issue>7</issue>):<fpage>467</fpage>&#x2013;<lpage>73</lpage>.
                    <pub-id pub-id-type="pmid">30178033</pub-id>
                    <pub-id pub-id-type="doi">10.7326/M18-0850</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Moher</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shamseer</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Clarke</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.</article-title>
                    <source>

                        <italic toggle="yes">Syst Rev.</italic>
</source>
                    <year>2015</year>;<volume>4</volume>(<issue>1</issue>):<fpage>1</fpage>.
                    <pub-id pub-id-type="pmid">25554246</pub-id>
                    <pub-id pub-id-type="doi">10.1186/2046-4053-4-1</pub-id>
                    <pub-id pub-id-type="pmcid">4320440</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report31779">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14604.r31779</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>New</surname>
                        <given-names>Karen</given-names>
                    </name>
                    <xref ref-type="aff" rid="r31779a1">1</xref>
                    <xref ref-type="aff" rid="r31779a2">2</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-6196-2452</uri>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>August</surname>
                        <given-names>Deanne</given-names>
                    </name>
                    <xref ref-type="aff" rid="r31779a3">3</xref>
                    <xref ref-type="aff" rid="r31779a1">1</xref>
                    <xref ref-type="aff" rid="r31779a4">4</xref>
                    <role>Co-referee</role>
                </contrib>
                <aff id="r31779a1">
                    <label>1</label>School of Nursing, Midwifery and Social Work, University of Queensland, Brisbane, Qld, Australia</aff>
                <aff id="r31779a2">
                    <label>2</label>School of Health and Behavioural Science, University of the Sunshine Coast, Buderim, Qld, Australia</aff>
                <aff id="r31779a3">
                    <label>3</label>Grantley Stable Neonatal Unit, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia</aff>
                <aff id="r31779a4">
                    <label>4</label>School of Medicine and Dentistry, James Cook University, Townsville, Qld, Australia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>11</day>
                <month>3</month>
                <year>2022</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 New K and August D</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport31779" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13359.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Thank you for the opportunity to provide a peer review report on your protocol for a scoping review of neonatal emollient therapy and massage practices throughout sub-Saharan Africa. The focus of the review is broad and is a large undertaking for which you are congratulated. The protocol overall articulates the scope and methods for the review, which are appropriate, however, there are some linkages missing for the reader. For example, the linkage between the rationale and review questions and outcomes. Increasing the clarity around these areas would enhance the protocol to allow replication by others.</p>
            <p> </p>
            <p> Presently the background/introduction discusses low birth weight and premature neonates in relation to infection and mortality linked with skin development and immature barrier function and that optimal skincare practices may offer interventions to address adverse outcomes. Additionally, emollient therapy may also promote growth, enhance neurodevelopmental outcomes and reduce hospital-acquired infection and mortality. Furthermore, cultural practices of the application of oils and other products and the effects of emollient therapy on newborn health are less known and the scoping review may address this area. The main objective of this scoping review is to create an accurate depiction of newborn skincare practices in Africa and the question addressing the objective is &#x201c;what are the common newborn skincare practices throughout Africa, with a focus on bathing, the application of oils and other products, and massage?&#x201d; The particular focus on bathing in this question warrants clarification in the introduction.</p>
            <p> </p>
            <p> The second research question &#x201c;what is the reported impact of newborn skincare practices throughout Africa, for example, the impact of emollient therapy on newborn postnatal survival, growth, infection and neurodevelopment?&#x201d;, does not appear to align with the main objective and perhaps there is a need for a second objective. Alternatively, the main objective could be broadened to: identify an accurate depiction 
                <bold>and the impact </bold>of newborn skincare practices in Africa; including bathing, emollients and their application?</p>
            <p> Newborn skin care practices are vast and while the inclusion and exclusion criteria for studies provides some restrictions to what practices are being considered for this review, the background/introduction does not provide the rationale for these. There is a lack of clarity to the suggested topical solutions of interest. For example, oils (how is this defined, and does it include any oil type applied to the newborn's skin?), other products (how is this defined and does this include traditional and commercially available products?), are emollients and other moisturisers excluded? Similarly, there is a lack of linkage or explanation of the relationship between bathing and emollient and massage; and growth and oil/emollient use. For the second question, while there is some rationale for emollient therapy in preterm infants, it is not clear what is meant by emollients for this review and as the review is focusing on all newborns (not just preterm newborns), the rationale for emollient therapy for all newborns and the outcomes is lacking.</p>
            <p> </p>
            <p> The protocol for this review would benefit from having definitions for the key terms and outcomes stated to increase clarity for future replication and research: 
                <list list-type="bullet">
                    <list-item>
                        <p>Newborn skin care practices (and to what time point. Does newborn mean neonate and therefore skincare practices within the first 28 days of life?).</p>
                    </list-item>
                    <list-item>
                        <p>Emollient (could this term be used to describe any ointment, cream, oil and moisturisers?).</p>
                    </list-item>
                    <list-item>
                        <p>Oil (if not included under emollient, then how is oil defined).</p>
                    </list-item>
                    <list-item>
                        <p>Other products (to include any traditional/natural or commercial product).</p>
                    </list-item>
                    <list-item>
                        <p>Massage (type of massage with or without the application of an emollient/oil).</p>
                    </list-item>
                    <list-item>
                        <p>Postnatal survival (for this review it is not clear the length of time the term postnatal is referring to &#x2013; this could be assumed to be 42 days post-birth, but stating this clearly would enhance the protocol/dataset at a later date).</p>
                    </list-item>
                    <list-item>
                        <p>Growth (is this inferring weight and length, and/or head circumference) and how measured and over what time period.</p>
                    </list-item>
                    <list-item>
                        <p>Infection (hospital-acquired only (could be very limiting to the Africa context, where homebirths occur and early discharge is common), local infection or laboratory-confirmed central infection or defined as reported in the individual studies). Over what time period.</p>
                    </list-item>
                    <list-item>
                        <p>Neurodevelopment (time point for outcome measurement, how measured etc).</p>
                    </list-item>
                </list> The guiding queries is a helpful section for the reader, much of which is clearly articulated and of relevance for this broad topic. However, there is the potential to better align some of the content of these guiding queries to the outcomes in the review questions. For example, Questions 19-24 appear focused on bathing (which links to the need for more rationale around bathing and the link with emollient therapy and massage practices) and cultural context. If the aim is to assess emollient practices including in the event of bathing that is fine, but this should be more related to the timing between application and post bathing. Q21 is a little ambiguous in asking was anything applied to the skin after bathing, which alludes to bathing and the application of a product that may be relevant to emollient therapy and/or massage, but this is not clear. Furthermore, Question 8 and the use of the term &#x2018;substance&#x2019; is a little confusing and in this context does &#x2018;substance&#x2019; substitute for oil, emollient and any other product? While the frequency of the application of the substance is being captured, the volume/amount is not which may also be important for outcomes. Further clarity around these guiding queries would enhance the ability for replication by others.</p>
            <p> </p>
            <p> Regarding the second research question and the impact of emollient therapy on survival, growth, infection and neurodevelopment &#x2013; the guiding queries do not appear to be directed at these outcomes. Although Question 14 asks about the health impacts it is not clear what is being captured by this question for the purpose of addressing the review questions or objective. &#x00a0;</p>
            <p> </p>
            <p> The search timeframe of 20 years would benefit from a rationale/justification. 20 years is a relatively long timeframe if the intent of the review is to determine contemporary practices. However, the timeframe may be very relevant if looking for changes over time or from when the first international Neonatal Guideline was published. Such a rationale would again increase the understanding of why this was done. This latest version of the protocol does not appear to have added the CINAHL database to be searched, a suggestion from the first reviewer, in which we agree as this would be an important database to capture top nursing literature which would be very relevant to the objective and questions for this scoping review.&#x00a0;</p>
            <p> </p>
            <p> The current title of the scoping review implies the review is focused on emollient therapy and massage as opposed to aligning with the main objective which appears to be creating a depiction and the impact of newborn skincare practices in sub-Saharan Africa. Thus, a review of the title to reflect the objective of the review more accurately may be warranted.</p>
            <p> </p>
            <p> The undertaking of this scoping review is important and will be valuable in identifying gaps in the evidence and therefore future research needs. We hope our feedback on this review protocol assists in increasing the clarity of the review in order to enhance the reporting of outcomes and datasets.</p>
            <p>Is the study design appropriate for the research question?</p>
            <p>Yes</p>
            <p>Is the rationale for, and objectives of, the study clearly described?</p>
            <p>Partly</p>
            <p>Are sufficient details of the methods provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Are the datasets clearly presented in a useable and accessible format?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Neonatology, neonatal nursing, neonatal skin development, injury and skincare, scoping review methods, qualitative and quantitative research methods.</p>
            <p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report31781">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14604.r31781</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Manasyan</surname>
                        <given-names>Albert</given-names>
                    </name>
                    <xref ref-type="aff" rid="r31781a1">1</xref>
                    <xref ref-type="aff" rid="r31781a2">2</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-6275-245X</uri>
                </contrib>
                <aff id="r31781a1">
                    <label>1</label>University of Alabama at Birmingham, Birmingham, AL, USA</aff>
                <aff id="r31781a2">
                    <label>2</label>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>7</day>
                <month>3</month>
                <year>2022</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Manasyan A</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport31781" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13359.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The protocol addresses a research question that may contribute to one of the top 3 contributors to neonatal mortality. I have only the following 2 comments/suggestions: 
                <list list-type="order">
                    <list-item>
                        <p>It may be interesting to understand if the location of birth impacts such practices - home deliveries having a higher chance of such practices versus facility deliveries. If this is of interest to the Investigators, this can be added to Table 2.</p>
                    </list-item>
                    <list-item>
                        <p>For the second objective ("...reported impact of newborn care practices"), would the investigators be able to review clinical data (i.e., Abx treatment) and KMC practices when evaluating the findings?</p>
                    </list-item>
                </list>
            </p>
            <p>Is the study design appropriate for the research question?</p>
            <p>Yes</p>
            <p>Is the rationale for, and objectives of, the study clearly described?</p>
            <p>Yes</p>
            <p>Are sufficient details of the methods provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Are the datasets clearly presented in a useable and accessible format?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Perinatal research, neonatal mortality, LMIC settings, primarily SSA).</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report31138">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.14604.r31138</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Talbert</surname>
                        <given-names>Alison W.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r31138a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-9328-6903</uri>
                </contrib>
                <aff id="r31138a1">
                    <label>1</label>KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>2</day>
                <month>9</month>
                <year>2021</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Talbert AW</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport31138" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.13359.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The protocol addresses a topic that has been chosen for future research in sub-Saharan Africa. The rationale and methods for the proposed scoping review are well described and I have only minor comments to make: 
                <list list-type="bullet">
                    <list-item>
                        <p>On search strategy: have you considered searching CINAHL (Cumulative Index to Nursing and Allied Health Literature) database? There may be some relevant publications there.</p>
                    </list-item>
                    <list-item>
                        <p>Remember to include details of studies excluded after full text review with reasons for exclusion as an appendix to the final review</p>
                    </list-item>
                </list>
            </p>
            <p>Is the study design appropriate for the research question?</p>
            <p>Yes</p>
            <p>Is the rationale for, and objectives of, the study clearly described?</p>
            <p>Yes</p>
            <p>Are sufficient details of the methods provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Are the datasets clearly presented in a useable and accessible format?</p>
            <p>Not applicable</p>
            <p>Reviewer Expertise:</p>
            <p>Paediatrics, epidemiology, nutrition</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
</article>
